AVDL logo

Avadel Pharmaceuticals plc (AVDL) Cash from investing

annual CFI:

$51.78M+$101.87M(+203.37%)
December 31, 2024

Summary

  • As of today (September 17, 2025), AVDL annual cash flow from investing activities is $51.78 million, with the most recent change of +$101.87 million (+203.37%) on December 31, 2024.
  • During the last 3 years, AVDL annual CFI has fallen by -$5.15 million (-9.04%).
  • AVDL annual CFI is now -35.03% below its all-time high of $79.70 million, reached on December 31, 2022.

Performance

AVDL Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

quarterly CFI:

-$8.10M-$20.41M(-165.74%)
June 1, 2025

Summary

  • As of today (September 17, 2025), AVDL quarterly cash flow from investing activities is -$8.10 million, with the most recent change of -$20.41 million (-165.74%) on June 1, 2025.
  • Over the past year, AVDL quarterly CFI has dropped by -$18.52 million (-177.69%).
  • AVDL quarterly CFI is now -119.16% below its all-time high of $42.25 million, reached on March 31, 2022.

Performance

AVDL quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

TTM CFI:

$23.47M-$18.52M(-44.10%)
June 1, 2025

Summary

  • As of today (September 17, 2025), AVDL TTM cash flow from investing activities is $23.47 million, with the most recent change of -$18.52 million (-44.10%) on June 1, 2025.
  • Over the past year, AVDL TTM CFI has dropped by -$46.98 million (-66.68%).
  • AVDL TTM CFI is now -72.74% below its all-time high of $86.11 million, reached on March 31, 2022.

Performance

AVDL TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AVDL Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+203.4%-177.7%-66.7%
3 y3 years-9.0%-176.0%-70.2%
5 y5 years+33.7%+90.0%+139.4%

AVDL Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.0%+203.4%-128.2%+91.3%-70.2%+136.7%
5 y5-year-35.0%+174.3%-119.2%+91.3%-72.7%+131.3%
alltimeall time-35.0%+162.5%-119.2%+91.3%-72.7%+124.0%

AVDL Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$8.10M(-165.7%)
$23.47M(-44.1%)
Mar 2025
-
$12.32M(-10.8%)
$41.99M(-17.8%)
Dec 2024
$51.78M(-203.4%)
$13.81M(+153.7%)
$51.06M(-22.6%)
Sep 2024
-
$5.44M(-47.8%)
$65.97M(-6.4%)
Jun 2024
-
$10.42M(-51.3%)
$70.45M(-310.3%)
Mar 2024
-
$21.39M(-25.5%)
-$33.51M(-32.8%)
Dec 2023
-$50.09M(-162.9%)
$28.72M(+189.3%)
-$49.83M(-9.0%)
Sep 2023
-
$9.93M(-110.6%)
-$54.73M(-14.5%)
Jun 2023
-
-$93.54M(-1946.4%)
-$64.02M(-259.4%)
Mar 2023
-
$5.07M(-78.7%)
$40.17M(-48.1%)
Dec 2022
$79.70M(+40.0%)
$23.81M(+3655.5%)
$77.35M(+14.3%)
Sep 2022
-
$634.10K(-94.0%)
$67.65M(-14.0%)
Jun 2022
-
$10.65M(-74.8%)
$78.63M(-8.7%)
Mar 2022
-
$42.25M(+199.4%)
$86.11M(+56.4%)
Dec 2021
$56.93M(-181.7%)
$14.11M(+21.6%)
$55.05M(+14.3%)
Sep 2021
-
$11.61M(-36.0%)
$48.18M(+100.2%)
Jun 2021
-
$18.14M(+62.1%)
$24.06M(-132.1%)
Mar 2021
-
$11.19M(+54.6%)
-$74.95M(+2.8%)
Dec 2020
-$69.72M(-280.1%)
$7.24M(-157.9%)
-$72.91M(-2.8%)
Sep 2020
-
-$12.50M(-84.5%)
-$75.02M(+26.0%)
Jun 2020
-
-$80.88M(-711.5%)
-$59.52M(-297.5%)
Mar 2020
-
$13.23M(+157.5%)
$30.14M(-21.3%)
Dec 2019
$38.72M(-204.7%)
$5.14M(+71.8%)
$38.30M(-22.3%)
Sep 2019
-
$2.99M(-66.0%)
$49.28M(-31.9%)
Jun 2019
-
$8.79M(-58.9%)
$72.41M(+9.1%)
Mar 2019
-
$21.39M(+32.7%)
$66.36M(-285.5%)
Dec 2018
-$36.98M(+135.6%)
$16.11M(-38.3%)
-$35.77M(-31.4%)
Sep 2018
-
$26.12M(+854.5%)
-$52.17M(-33.0%)
Jun 2018
-
$2.74M(-103.4%)
-$77.87M(+19.6%)
Mar 2018
-
-$80.74M(>+9900.0%)
-$65.14M(+297.5%)
Dec 2017
-$15.70M(-57.1%)
-$283.30K(-168.6%)
-$16.39M(+948.2%)
Sep 2017
-
$412.80K(-97.3%)
-$1.56M(+4.9%)
Jun 2017
-
$15.47M(-148.4%)
-$1.49M(-94.4%)
Mar 2017
-
-$31.99M(-320.0%)
-$26.69M(-25.2%)
Dec 2016
-$36.63M(+15.4%)
$14.54M(+2889.1%)
-$35.68M(-28.9%)
Sep 2016
-
$486.40K(-105.0%)
-$50.22M(-1.0%)
Jun 2016
-
-$9.72M(-76.3%)
-$50.71M(+23.7%)
Mar 2016
-
-$40.99M(+74.9%)
-$40.99M(+13.2%)
Dec 2015
-$31.73M(-26.4%)
-
-
Mar 2015
-
-$23.43M(-242.1%)
-$36.21M(-10.8%)
Dec 2014
-$43.08M
$16.49M(-150.1%)
-$40.57M(-26.4%)
Sep 2014
-
-$32.92M(-1001.6%)
-$55.11M(+145.7%)
Jun 2014
-
$3.65M(-113.1%)
-$22.43M(-14.4%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$27.79M(-1522.6%)
-$26.19M(-522.6%)
Dec 2013
$6.04M(-60.9%)
$1.95M(-907.3%)
$6.20M(+46.0%)
Sep 2013
-
-$242.00K(+117.2%)
$4.24M(-5.4%)
Jun 2013
-
-$111.40K(-102.4%)
$4.49M(-27.1%)
Mar 2013
-
$4.60M(+194.7%)
$6.16M(+69.0%)
Dec 2012
$15.45M(-4501.1%)
-
-
Jun 2012
-
$1.56M(-66.4%)
$3.64M(+307.0%)
Mar 2012
-
$4.64M(+863.3%)
$895.00K(-363.2%)
Dec 2011
-$351.00K(-105.8%)
$481.80K(-115.9%)
-$340.00K(-109.4%)
Sep 2011
-
-$3.04M(+155.8%)
$3.63M(-45.5%)
Jun 2011
-
-$1.19M(-134.9%)
$6.67M(-15.1%)
Mar 2011
-
$3.41M(-23.6%)
$7.86M(+76.4%)
Dec 2010
$6.03M(-124.8%)
$4.46M(-233.9%)
$4.46M(-131.8%)
Dec 2009
-$24.26M(-2763.2%)
-
-
Dec 2008
$911.00K(-106.9%)
-
-
Dec 2007
-$13.23M(-118.2%)
-$3.33M(-40.8%)
-$13.99M(+31.2%)
Sep 2007
-
-$5.62M(+20.3%)
-$10.67M(+111.4%)
Jun 2007
-
-$4.67M(+1152.6%)
-$5.05M(-141.9%)
Mar 2007
-
-$373.00K(-103.0%)
$12.05M(-66.5%)
Dec 2006
$72.67M(-1714.8%)
-
-
Jun 2006
-
$12.42M(+3.5%)
$35.92M(+100.2%)
Mar 2006
-
$12.00M(+2427.8%)
$17.95M(-516.8%)
Dec 2005
-$4.50M(-316.6%)
$474.60K(-95.7%)
-$4.31M(-134.6%)
Sep 2005
-
$11.03M(-298.5%)
$12.43M(-300.5%)
Jun 2005
-
-$5.56M(-45.8%)
-$6.20M(+49.8%)
Mar 2005
-
-$10.25M(-159.6%)
-$4.14M(-299.2%)
Dec 2004
$2.08M(-102.5%)
$17.21M(-326.6%)
$2.08M(-102.1%)
Sep 2004
-
-$7.60M(+117.1%)
-$97.98M(+8.4%)
Jun 2004
-
-$3.50M(-13.3%)
-$90.39M(+4.0%)
Mar 2004
-
-$4.04M(-95.1%)
-$86.93M(+4.9%)
Dec 2003
-$82.85M(+5685.5%)
-$82.85M(<-9900.0%)
-$82.85M(<-9900.0%)
Sep 2003
-
$0.00(-100.0%)
$4000.00(0.0%)
Jun 2003
-
-$39.00K(-190.7%)
$4000.00(-90.7%)
Mar 2003
-
$43.00K(-98.5%)
$43.00K(-98.5%)
Dec 2002
-$1.43M(+21.9%)
-
-
Dec 2001
-$1.18M(+59.4%)
-
-
Dec 2000
-$737.00K(-121.7%)
-
-
Dec 1999
$3.39M(+140.2%)
-
-
Dec 1998
$1.41M(-188.3%)
-
-
Mar 1998
-
$2.80M(-1500.0%)
$2.80M(-1500.0%)
Dec 1997
-$1.60M(-82.8%)
-
-
Dec 1996
-$9.30M
-
-
Mar 1996
-
-$200.00K
-$200.00K

FAQ

  • What is Avadel Pharmaceuticals plc annual cash flow from investing activities?
  • What is the all time high annual CFI for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual CFI year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly CFI year-on-year change?
  • What is Avadel Pharmaceuticals plc TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc TTM CFI year-on-year change?

What is Avadel Pharmaceuticals plc annual cash flow from investing activities?

The current annual CFI of AVDL is $51.78M

What is the all time high annual CFI for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual cash flow from investing activities is $79.70M

What is Avadel Pharmaceuticals plc annual CFI year-on-year change?

Over the past year, AVDL annual cash flow from investing activities has changed by +$101.87M (+203.37%)

What is Avadel Pharmaceuticals plc quarterly cash flow from investing activities?

The current quarterly CFI of AVDL is -$8.10M

What is the all time high quarterly CFI for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly cash flow from investing activities is $42.25M

What is Avadel Pharmaceuticals plc quarterly CFI year-on-year change?

Over the past year, AVDL quarterly cash flow from investing activities has changed by -$18.52M (-177.69%)

What is Avadel Pharmaceuticals plc TTM cash flow from investing activities?

The current TTM CFI of AVDL is $23.47M

What is the all time high TTM CFI for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high TTM cash flow from investing activities is $86.11M

What is Avadel Pharmaceuticals plc TTM CFI year-on-year change?

Over the past year, AVDL TTM cash flow from investing activities has changed by -$46.98M (-66.68%)
On this page